What drug should be used to treat primary postpartum haemorrhage? Evidence update - Summary of a Cochrane Review

International Public Health, LSTM (2009) What drug should be used to treat primary postpartum haemorrhage? Evidence update - Summary of a Cochrane Review. Liverpool, Effective Health Care Research Consortium, Liverpool School of Tropical Medicine.

Preview

Text MaternalHealth_CD003249_Apr09_Final.pdf - Published Version Available under License Creative Commons Attribution No Derivatives. Download (191kB)

Abstract

Injectable oxytocin or ergometrine.

Item Type:	Other
Corporate Authors:	Effective Health Care Research Consortium
Additional Information:	Produced by the Effective Health Care Research Consortium (www.liv.ac.uk/evidence), Liverpool School of Tropical Medicine, supported by the Department for International Development UK. Adapted from Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD003249. DOI: 10.1002/14651858. CD003249.pub2 Evidence Update published in April 2009.
Uncontrolled Keywords:	Cochrane Review CD003249, Ergonovine, Hysterectomy, Maternal Mortality, Misoprostol, Oxytocics, Oxytocin, Postpartum Hemorrhage, evidence update
Subjects:	WA Public Health > Health Problems of Special Population Groups > WA 310 Maternal welfare WQ Obstetrics > WQ 20 Research (General) WQ Obstetrics > Labor > WQ 330 Complications of labor
Faculty: Department:	Clinical Sciences & International Health > International Public Health Department
Depositing User:	Martin Chapman
Date Deposited:	05 Sep 2011 11:14
Last Modified:	19 Feb 2025 14:33
URI:	https://archive.lstmed.ac.uk/id/eprint/2326

Statistics

View details

Actions (login required)

Edit Item